V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250000331 | 250007905 | 1.6 | 87.5 | Palliative (P) | 2019-05-11 | 2019-05-29 | IPILIMUMAB + NIVOLUMAB | Y | N | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 101320011 |
| 250000648 | 250007906 | 1.68 | 89.6 | 03 | 2018-07-02 | 2018-07-05 | null | 02 | null | CAPECITABINE + OXALIPLATIN | 100068845 |
| 250000769 | 250007910 | 1.65 | 63.4 | Palliative (P) | null | 2020-06-05 | Trial Unspecified | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101062710 |
| 250000771 | 250007911 | 0 | 65 | null | 2019-07-25 | 2020-02-22 | LIPOSOMAL DOXORUBICIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101609837 |
| 250000823 | 250007913 | 1.54 | 70 | Palliative (P) | 2020-02-03 | 2020-02-03 | Trial Unspecified | 2 | N | EW EUROEWING 2012 ARM B VDC/IE | 100791807 |
| 250000919 | 250007914 | 1.68 | 94.6 | null | null | 2020-02-26 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CYCLOPHOSPHAMIDE | 101233838 |
| 250000920 | 250007915 | 1.75 | 11.2 | Palliative (P) | 2018-09-14 | 2018-10-05 | null | 02 | null | DOXORUBICIN | 100989360 |
| 250000974 | 250007916 | null | null | null | null | 2020-03-23 | Cetuximab + CISPLATIN + FLUOROURACIL | null | Y | DINUTUXIMAB BETA | 101827919 |
| 250001052 | 250007917 | null | null | null | 2021-02-27 | 2021-02-27 | Olaratumab | 02 | N | BACILLUS CALMETTE-GUERIN | 101706684 |
| 250001057 | 250007918 | null | 0 | Palliative (P) | null | 2019-10-30 | Cisplatin | 02 | N | DOXORUBICIN | 101410777 |
| 250001060 | 250007919 | 1.76 | 64 | Curative (C) | null | 2019-10-28 | Sunitinib | N | N | CARBOPLATIN + PACLITAXEL | 100462361 |
| 250001074 | 250007920 | null | null | Palliative (P) | 2016-09-11 | 2017-10-23 | Sunitinib | 02 | null | CAPECITABINE + CARBOPLATIN | 100864065 |
| 250001115 | 250007922 | 1.83 | 46.3 | Palliative (P) | null | 2020-12-08 | null | 02 | N | SUNITINIB | 101513283 |
| 250001146 | 250007925 | 1.01 | 49.15 | Palliative (P) | null | 2021-09-09 | null | 02 | N | TRIAL UNSPECIFIED | 100099766 |
| 250001208 | 250007926 | 1.8 | 81.4 | Palliative (P) | 2019-09-06 | 2019-10-26 | null | 02 | N | TRIAL UNSPECIFIED | 101544258 |
| 250001319 | 250007927 | 1.61 | 78.2 | Palliative (P) | null | 2021-06-18 | CISPLATIN + ETOPOSIDE | N | N | WT SIOP 2002 01 POST OP VINC ALONE | 101740740 |
| 250001320 | 250007928 | 0 | 95.4 | 03 | null | 2019-05-27 | Carbo F | null | null | PACLITAXEL | 100015616 |
| 250001331 | 250007929 | null | null | Curative (C) | null | 2021-08-23 | null | null | N | TRIAL UNSPECIFIED | 100604720 |
| 250001358 | 250007930 | 1.83 | 86.8 | Palliative (P) | 2019-05-05 | 2019-07-04 | AVELUMAB + AXITINIB | 02 | N | CARBOPLATIN + FLUOROURACIL | 100992873 |
| 250001610 | 250007933 | null | null | null | 2021-07-14 | 2021-07-24 | Carboplatin AUC 2 - 5 | null | null | CARBOPLATIN + FLUOROURACIL | 100857543 |
| 250001677 | 250007935 | 1.73 | 70 | 03 | 2020-01-08 | 2020-02-03 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | IRINOTECAN + CISPLATIN + MITOMYCIN | 100034115 |
| 250001697 | 250007937 | 1.56 | 48.8 | Palliative (P) | 2020-01-01 | 2020-01-15 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101840571 |
| 250001761 | 250007938 | null | null | null | null | 2018-06-16 | CISPLATIN + FLUOROURACIL | null | N | ENZALUTAMIDE | 100399430 |
| 250001811 | 250007940 | null | null | Curative (C) | null | 2021-02-06 | null | 02 | N | NIRAPARIB | 100389389 |
| 250001892 | 250007941 | null | null | null | null | 2019-04-27 | Fluorouracil+Mitomycin+RT (Anal Ca) | null | N | DINUTUXIMAB BETA | 101074705 |
| 250002014 | 250007942 | null | null | Palliative (P) | null | 2020-05-04 | Docetaxel 75mg/m2 (21 day) | null | N | CISPLATIN + PEMETREXED | 100115437 |
| 250002228 | 250007944 | null | null | null | 2018-05-17 | 2018-06-01 | Trial Unspecified | 02 | null | CAPECITABINE + CISPLATIN | 101712864 |
| 250002275 | 250007945 | 1.8 | 74.5 | null | 2019-06-17 | 2019-06-30 | Trial Unspecified | 02 | null | TRABECTEDIN | 100548739 |
| 250001320 | 250007949 | 1.79 | 81 | 03 | 2017-06-01 | 2017-06-18 | null | 02 | N | CETUXIMAB | 100015616 |
| 250001724 | 250007950 | 1.8 | 0 | null | 2021-04-06 | 2021-04-07 | CARBOPLATIN + PACLITAXEL | 02 | N | TRIAL UNSPECIFIED | 101871038 |
| 250001986 | 250007951 | 1.6 | 19.1 | Neo-adjuvant (N) | 2018-10-03 | 2018-10-07 | Cisplatin + Pemetrexed | 02 | null | PANITUMUMAB | 100407895 |
| 250002512 | 250007953 | null | null | null | 2019-07-02 | 2019-09-03 | null | 02 | null | GEMCITABINE | 101653937 |
| 250001222 | 250008110 | 1.76 | 56.3 | null | null | 2015-04-24 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101336301 |
| 250001225 | 250008112 | 1.62 | 96.4 | null | null | 2019-11-07 | null | null | null | CARBOPLATIN + GEMCITABINE | 100400110 |
| 250001249 | 250008115 | 1.7 | 83.5 | null | null | 2021-08-08 | null | null | null | CARBOPLATIN + GEMCITABINE | 100866928 |
| 250001250 | 250008116 | 1.83 | 58.1 | Curative (C) | 2021-07-28 | 2021-08-11 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101204830 |
| 250001262 | 250008118 | 1.72 | 100 | null | null | 2020-09-15 | null | null | null | CISPLATIN + GEMCITABINE | 101115459 |
| 250001271 | 250008119 | 1.49 | null | null | 2018-07-12 | 2018-08-31 | null | 02 | null | PEMBROLIZUMAB | 101775036 |
| 250001276 | 250008121 | 1.84 | 76 | Palliative (P) | 2020-03-04 | 2020-03-10 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100253875 |
| 250001278 | 250008122 | 1.62 | 69.9 | Palliative (P) | 2018-01-09 | 2018-01-26 | null | 02 | N | NIVOLUMAB | 101395958 |
| 250001279 | 250008123 | 1.85 | 88 | Palliative (P) | 2019-06-20 | 2019-06-26 | null | 02 | N | NIVOLUMAB | 101831716 |
| 250001287 | 250008124 | 1.63 | 68.4 | null | null | 2017-04-01 | null | null | null | CISPLATIN + GEMCITABINE | 100183926 |
| 250001292 | 250008125 | 1.79 | 73 | Palliative (P) | 2017-08-14 | 2017-08-25 | null | 02 | N | CISPLATIN + GEMCITABINE | 100620150 |
| 250001300 | 250008126 | 1.53 | 127.65 | Palliative (P) | null | 2018-07-30 | PEMBROLIZUMAB | null | N | PEMBROLIZUMAB | 101418659 |
| 250001309 | 250008127 | 1.53 | 58.1 | null | 2019-06-17 | 2019-07-04 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100560789 |
| 250001320 | 250008128 | 1.66 | 77.6 | Palliative (P) | 2017-08-07 | 2017-08-07 | null | 02 | N | PEMBROLIZUMAB | 100015616 |
| 250001322 | 250008129 | 1.86 | 100.5 | null | null | 2021-05-25 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100804895 |
| 250001326 | 250008130 | 0.02 | 56 | null | 2020-05-22 | 2020-06-01 | null | 02 | null | PEMBROLIZUMAB | 100878185 |
| 250001334 | 250008132 | 1.67 | 0 | null | null | 2017-12-04 | NIVOLUMAB | null | null | NIVOLUMAB | 101577047 |
| 250001335 | 250008133 | null | 83.6 | Palliative (P) | 2018-04-08 | 2018-04-09 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | PEMBROLIZUMAB | 101226814 |